The Future of Performance Enhancing Drugs and Testing
https://reachmd.com/programs/focus-on-sports-medicine/the-future-of-performance-enhancing-drugs-and-testing/3001/
Looking beyond steroids in professional sports; what are the major drugs, how do they work, and who is using them? Looking at the red blood cell-boosting EPO, HGH, and the future of testing for performance enhancing drugs in sports is your host, Dr. Gary Kohn. Joining him is one of the world's premi
Best Practices for Existing Epidermal Growth Factor Receptor (EGFR) Inhibitor Agents
https://reachmd.com/programs/global-oncology-academy/best-practices-for-existing-epidermal-growth-factor-receptor-egfr-inhibitor-agents/9541/
The management of metastatic colorectal cancer (mCRC) and metastatic and recurrent loco-regional squamous cell cancer of the head and neck (SCCHN) continues to evolve, not only as new agents reach the clinic but also new understandings of how best to utilize existing agents to optimize clinical outc
A New Paradigm for the Treatment of Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/a-new-paradigm-for-the-treatment-of-type-2-diabetes/4803/
Insulin resistance in muscle, liver and ß-cell represent the core pathophysiologic defects in type 2 diabetes. In addition, the ominous octet all play important roles in the development of glucose intolerance in people with type 2 diabetes. How will this new paradigm shift our understanding in the w
Dialogue with the Experts: Best Practices in NSCLC
https://reachmd.com/programs/project-oncology/dialogue-with-the-experts-best-practices-in-nsclc/9626/
Lung Cancer is the leading cause of cancer death and the second most diagnosed cancer in both men and women in the US. Incidence rates vary from state to state, but are of concern in the South.1 These sobering statistics are compounded by the documented variations in non-small-cell lung cancer (NSC
New Recommendations for STEMI and PCI
https://reachmd.com/programs/heart-matters/new-recommendations-for-stemi-and-pci/4962/
What are the 2009 recommendations for best managing ST-segment-elevation myocardial infarction, or STEMI, and the need for percutaneous coronary intervention, or PCI? Dr. Judith Hochman, the Harold Snyder Family Professor of Cardiology and clinical chief of cardiology at the New York University (NYU
Cellular Vaccine Development as Cancer Therapy
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/cellular-vaccine-development-as-cancer-therapy/4595/
What are cellular vaccines and how do they differ from what we think of as conventional vaccines? What are the various types of approaches that we can potentially use for inducing anti-cancer immunity? Dr. Don Siegel, vice chair and professor of pathology and laboratory medicine at Penn Medicine, ta
CMV Infection After Transplant: Who’s at Risk and How to Manage?
https://reachmd.com/programs/medical-industry-feature/cmv-infection-after-transplant-whos-at-risk-and-how-to-manage/15201/
Find out which of our patients are at risk for cytomegalovirus infection after HCT and SOT and how we can manage them.
Cardiology Among the Constellations: Exploring Microgravity & Space Flight
https://reachmd.com/programs/heart-matters/cardiology-among-constellations-exploring-microgravity-and-space-flight/12207/
How can low gravity and space flight impact cardiac function in the human body?
Weekly Check-Up | January 11th 2016
https://reachmd.com/programs/video-library/weekly-check-january-11th-2016/7866/
Welcome to the Weekly Check-up on ReachMD for the week of January 11th, 2016. Check out this week's programs: Depression Among Resident Patients An In-Depth Discussion of Multiple Myeloma (CME) The Path to Lung Transplantation: Roles of Extracorporeal Membrane Oxygenation (ECMO) Implemen
Weekly Check-up | September 5th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-september-5th-2016/8334/
Welcome to the Weekly Check-up on ReachMD for the week of September 5th, 2016.